> ## Content Index
> Fetch the complete content index at: https://members.americanhealthintel.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Cencora to buy American Oncology Network
- URL: https://members.americanhealthintel.com/2026-10-21-ledger/
- Published: 2026-10-21T18:17:30.000Z
- Updated: 2026-10-21T18:17:30.000Z
- Description: Plus: Elevance Q3 ratio improves, membership shrinks. The day's rules, money, and enforcement, sourced and tiered below.
- Author: American Health Intel

Plus: Elevance Q3 ratio improves, membership shrinks. The day's rules, money, and enforcement, sourced and tiered below.

| American Health Intel Rules · Money · Medicine · Decoded daily The Ledger Wednesday, October 21, 2026 Cencora to buy American Oncology Network Plus: Elevance Q3 ratio improves, membership shrinks. The day's rules, money, and enforcement, sourced and tiered below. ![](https://americanhealthintel.com/email/pulse-divider.png) Deal Confidence: High Cencora, the drug wholesaler, will buy American Oncology Network, a physician-led cancer care network of 350+ providers in 21 states, at a $2.4B enterprise value. $2.3B at closing plus up to $100M in contingent value rights. If holders roll over 25%, Cencora pays about $1.7B for 75%. It owns about 4% now. Closing date not stated. Why it matters A drug wholesaler is moving deeper into running cancer practices, which can shift who has leverage when drug prices and contracts are negotiated. Watch for the closing timeline and any antitrust review, neither of which is stated. Sources: [SEC](https://www.sec.gov/Archives/edgar/data/0001140859/000110465926117576/tm2627778d1%5Fex99-1.htm?ref=members.americanhealthintel.com) Earnings Confidence: High UPDATE: Elevance, the health insurer, posted a 90.6% Q3 benefit expense ratio, down from 91.3%, and now sees 2026 adjusted EPS of at least $29.00. Revenue rose just 0.7% to $50.4B. Medicare Advantage members fell 15.5% to 1.9M, Medicaid 4.9% to 8.2M. Nine-month results carry a $935M CMS risk adjustment charge. QUOTE: https://x.com/amhealthintel/status/2112264525219332135 Why it matters The insurer's medical cost ratio improved on a smaller, repriced book rather than on revenue growth. Watch whether membership losses in Medicare Advantage and Medicaid continue. Sources: [SEC](https://www.sec.gov/Archives/edgar/data/0001156039/000115603926000068/a3q2026elvearningsrelease.htm?ref=members.americanhealthintel.com) Also today Hologic to buy Reveal Genomics [Read](https://americanhealthintel.com/editions/2026-10-21-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#hologic-reveal-genomics-her2dx) 1046Records$62.4BEnforcement44Deadlines297Rules [Read this issue + the trackers](https://americanhealthintel.com/editions/2026-10-21-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) Pick your field on the site and every story tells you what it means for you. Reply to this email and tell us what you want covered. We read everything. We show our work. We score our own calls. [Track record](https://americanhealthintel.com/ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Calendar](https://americanhealthintel.com/calendar/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Enforcement](https://americanhealthintel.com/enforcement/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [X](https://x.com/amhealthintel?ref=members.americanhealthintel.com) · [LinkedIn](https://www.linkedin.com/company/american-health-intel?ref=members.americanhealthintel.com) News and analysis, not legal, medical, coding, or investment advice.You subscribed at americanhealthintel.com · [Unsubscribe](%%{unsubscribe%5Furl}%%) |
| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |